NCT06676618 Effect of Multimodal Exercise Training in Patients With Multiple Sclerosis
| NCT ID | NCT06676618 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University - Cerrahpasa |
| Condition | Multiple Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-02-10 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-02-10 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to examine the effects of multimodal exercise training including aerobic, strengthening and balance exercises via face-to-face and asynchronous video-based telerehabilitation on disease activity, disability level, aerobic capacity, physical activity level, balance, fatigue level and quality of life in individuals with multiple sclerosis. Therefore, this study consists of two hypotheses. Hypotheses: H0: Multimodal exercise training has no effect on disease activity and functional status in patients with multiple sclerosis H1: Multimodal exercise training has effects on disease activity and functional status in patients with multiple sclerosis
Eligibility Criteria
Inclusion Criteria: * Being diagnosed with multiple sclerosis by a neurologist * Volunteering to participate in the study * Being ambulatory * EDSS between 3.0-5.5 * Being literate * Having internet access * Not having participated in a standardized physiotherapy and rehabilitation program in the last 3 months Exclusion Criteria: * Having an orthopedic problem affecting its mobility * Having psychiatric problems, severe cognitive impairment, or epilepsy in addition to the MS diagnosis * Blurred vision or visual impairment * Pregnancy * Having had an attack or received corticosteroid treatment 3 months before participating in the study * Having a disease affecting immunological parameters (infection, cancer, etc.)
Contact & Investigator
Pelin Vural, MSc
PRINCIPAL INVESTIGATOR
Istanbul University-Cerrahpasa Institute of Postgraduate Education
Frequently Asked Questions
Who can join the NCT06676618 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06676618 currently recruiting?
Yes, NCT06676618 is actively recruiting participants. Contact the research team at pelinvural7@gmail.com for enrollment information.
Where is the NCT06676618 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06676618 clinical trial?
NCT06676618 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Pelin Vural, MSc at Istanbul University-Cerrahpasa Institute of Postgraduate Education. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.